A First-in-Human Single and Multiple Ascending Dose Study of MT-501

Clinical trial NCT06762457 · COMPLETED

Trial details

NCT number: NCT06762457
Sponsor: Mirador Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2024-12-11
Primary completion: 2025-05-22
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.